slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,568
Current window 40,081-40,110
Pages 2,019
Rows per page 30
Component
40,081-40,110 of 60,568
44
Cano Health | Investor Presentation Deck | 48 slidesCano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations 1 hit
45
Includes detailed footnotes explaining the non-GAAP adjustments and the definition of the metrics used.Cano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations 1 hit
07
Uses a diamond-shaped diagram to represent the core pillars of the care model and growth strategy.Cano Health | Results Presentation Deck | 19 slides · Cano Health
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
The chart shows a J-curve effect for de novo medical center profitability.Cano Health | Results Presentation Deck | 19 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Pareto Focus1 hit
10
Includes non-GAAP financial measure disclaimers.Cano Health | Results Presentation Deck | 19 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Pareto Focus1 hit
16
Includes footnotes defining Medical Cost Ratio and Adjusted EBITDA, and a note on rounding.Cano Health | Results Presentation Deck | 19 slides · Cano Health
Conference presentation Investor relations Beat · Financials1 hit
17
The slide includes a detailed reconciliation table and a legend for specific adjustments (A-F).Cano Health | Results Presentation Deck | 19 slides · Cano Health
Conference presentation Investor relations Beat · Financials1 hit
04
The slide uses a Gantt-style chart to map drug candidates against development phases.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
06
Includes Kaplan-Meier survival curves and a comparative table of clinical outcomes.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · Problem StatementLoop · Cost Of Inaction1 hit
12
The chart is a 'spider plot' or 'swimmer plot' variant showing % change in tumor size over time.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
14
Data table comparing All patients vs RANO HGG Responders vs RANO HGG and/or LGG Responders across survival and clinical metrics.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
15
The table uses a color-coded heatmap (green/pink) to indicate positive vs negative characteristics of trial design and outcomes.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
11
The chart illustrates a specific 24-hour period where energy prices spiked, showing the difference between mining revenue and energy costs.Cipher Mining | Investor Presentation Deck | 18 slides · Cipher Mining
Pitch deck Investor relations 1 hit
13
Financial statement disclosure slide.Cipher Mining | Investor Presentation Deck | 18 slides · Cipher Mining
Pitch deck Investor relations Beat · Financials1 hit
14
Note: In thousands, except for share and per share amountsCipher Mining | Investor Presentation Deck | 18 slides · Cipher Mining
Pitch deck Investor relations Beat · Financials1 hit
18
Note: In thousandsCipher Mining | Investor Presentation Deck | 18 slides · Cipher Mining
Pitch deck Investor relations Beat · Financials1 hit
04
The chart uses a Gantt-style visualization to represent clinical trial progress across different indications.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
11
The table highlights Partial Response rates with a red border.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Hypothesis Test1 hit
16
The table highlights patient age, gender, ECOG status, prior therapies, and BTC subtypes.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
22
The table compares a mixed 2L/3L cohort (CTX-009) against historical 1L and 2L benchmarks.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Confession1 hit
25
The slide uses a table for market sizing and a structured layout to contrast 1L and 2L treatment options.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
27
The slide uses a table for epidemiological data and a horizontal layout to represent the treatment pathway.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
36
The slide shows tumor volume over time, tumor growth inhibition percentages, individual tumor growth trajectories, and a summary table of cure rates.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
23
The table reconciles Net Income to Adjusted EBITDA by adding back depreciation, interest, taxes, and equity-based compensation, and subtracting interest income.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations 1 hit
24
The table shows a clear trend of improving profitability from a net loss to a positive Adjusted EBITDA.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations 1 hit
25
The table provides a breakdown of adjustments including capital expenditures and proceeds from asset sales to arrive at Free Cash Flow.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations 1 hit
07
Includes footnotes explaining adjustments for goodwill impairment, restructuring, and derivative liabilities.Cyxtera | Results Presentation Deck | 16 slides · Cyxtera
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
14
Numbers are in millions; table includes adjustments for equity-based compensation, goodwill impairment, and other non-recurring items.Cyxtera | Results Presentation Deck | 16 slides · Cyxtera
Conference presentation Investor relations Beat · Action1 hit
15
Includes detailed footnotes explaining debt adjustments and leverage calculations.Cyxtera | Results Presentation Deck | 16 slides · Cyxtera
Conference presentation Investor relations Beat · Action1 hit
11
Diploma | Results Presentation Deck | 29 slidesDiploma | Results Presentation Deck | 29 slides · Diploma PLC
Conference presentation Investor relations Beat · Interest1 hit